Andon Health Co., Ltd. (002432.SZ)
CNY 42.22
(-0.31%)
CNY 42.22
(-0.31%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 2.01 Billion | 18.22 Billion | 293.11 Million | 461.62 Million | -43.69 Million | -104.17 Million |
| Net Income | 1.25 Billion | 16.48 Billion | 934.4 Million | 236.82 Million | 27.05 Million | -2.85 Million |
| Depreciation & Amortization | 107.62 Million | 106.04 Million | 89.36 Million | 62.77 Million | 59.52 Million | 54.96 Million |
| Deferred income taxes | 88.92 Million | 882.4 Million | -30.38 Million | -8.07 Million | -8.11 Million | -1.33 Million |
| Stock-based compensation | 190.53 Million | 164.68 Million | 9.17 Million | 2.04 Million | - | - |
| Change in working capital | 743 Million | 818.16 Million | -719.23 Million | -82.6 Million | 26.74 Million | -136.59 Million |
| Other non-cash items | -480.44 Million | -233.71 Million | 9.78 Million | 250.65 Million | -157.01 Million | -19.68 Million |
| Investing Cash Flow | -4.43 Billion | -12.94 Billion | -357.22 Million | -108.4 Million | -32.65 Million | -210.24 Million |
| Investments in PPE | -212.65 Million | -211.89 Million | -70.44 Million | -53.76 Million | -60.74 Million | -179.69 Million |
| Acquisitions | -6.62 Million | 462.79 Thousand | 102.9 Thousand | -18.82 Million | 42.46 Million | -16.93 Million |
| Investment purchases | -14.41 Billion | -13.98 Billion | -618.34 Million | -1.13 Billion | -663.7 Million | -33.3 Million |
| Sales/Maturities of investments | 10.2 Billion | 1.24 Billion | 326.47 Million | 1.11 Billion | 645.49 Million | 6.39 Million |
| Other Investing Activities | -105.7 Thousand | 6.82 Million | 4.98 Million | -15 Million | 3.82 Million | 13.29 Million |
| Financing Cash Flow | -922.78 Million | -275.81 Million | 65 Million | 155.69 Million | -179.85 Million | -103.38 Million |
| Debt repayment | -1.26 Billion | -318.42 Million | -253.62 Million | -9.48 Million | -150.71 Million | -442.35 Million |
| Dividends payments | -1.17 Billion | -319.17 Million | -28 Million | -6.67 Million | -8.68 Million | -6.3 Million |
| Common Stock Repurchased | -999.99 Million | -139.14 Million | -199.83 Million | 820 Thousand | - | - |
| Common Stock Issuance | -975.56 Million | 139.14 Million | 31.61 Million | -820 Thousand | - | - |
| Other Financing Activities | -9.2 Million | 364.64 Million | 523.52 Million | 171.85 Million | -20.46 Million | 345.28 Million |
| Accounts receivables | 401.75 Million | 353.29 Million | -718.62 Million | -68.84 Million | -16.52 Million | -17.29 Million |
| Accounts payables | -279.88 Million | -196.61 Million | 361.91 Million | 81.41 Million | 34.28 Million | -74.91 Million |
| Inventory | 400.21 Million | -220.91 Million | -332.14 Million | -87.09 Million | 17.09 Million | -43.04 Million |
| Other working capital | 220.91 Million | 882.4 Million | -30.38 Million | -8.07 Million | -8.11 Million | -93.55 Million |
| Cash at beginning of period | 5.44 Billion | 540.82 Million | 554.17 Million | 73.28 Million | 328.74 Million | 738.01 Million |
| Cash at end of period | 2.24 Billion | 5.55 Billion | 540.82 Million | 554.17 Million | 73.28 Million | 328.74 Million |
| Capital Expenditure | -212.65 Million | -211.89 Million | -70.44 Million | -53.76 Million | -60.74 Million | -179.69 Million |
| Effect of forex changes on cash | 69.44 Million | 15.8 Million | -14.24 Million | -28.01 Million | 745.37 Thousand | 8.52 Million |
| Net cash flow / Change in cash | -3.19 Billion | 5.01 Billion | -13.35 Million | 480.89 Million | -255.46 Million | -409.27 Million |
| Free Cash Flow | 1.8 Billion | 18 Billion | 222.66 Million | 407.85 Million | -104.43 Million | -283.86 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 766.88 Million | 354.33 Million | 247.42 Million | 1.25 Billion | 354.87 Million | 110.91 Million |
| Depreciation & Amortization | - | 20.72 Million | 20.72 Million | 107.62 Million | 22.6 Million | -34.35 Million |
| Deferred income taxes | - | - | - | 88.92 Million | - | 945.67 Million |
| Stock-based compensation | - | 40.23 Million | - | 190.53 Million | 190.53 Million | -156.94 Million |
| Change in working capital | - | 27.69 Million | - | 743 Million | 1.02 Billion | -833.38 Million |
| Other non-cash items | -235.5 Million | 33.58 Million | 55.39 Million | -480.44 Million | -310.76 Million | 81.16 Million |
| Investing Cash Flow | 944.02 Million | 259.54 Million | -1.89 Billion | -4.43 Billion | 734.03 Million | -1.89 Billion |
| Investments in PPE | -6.97 Million | -27.47 Million | -815.44 Thousand | -212.65 Million | -14.78 Million | -6.28 Million |
| Acquisitions | 130.49 Thousand | 391.97 Thousand | 322.06 Thousand | -6.62 Million | -6.81 Million | 170.5 Thousand |
| Investment purchases | -4.9 Billion | -2.56 Billion | -5.2 Billion | -14.41 Billion | -1.78 Billion | -3.66 Billion |
| Sales/Maturities of investments | 5.85 Billion | 2.84 Billion | 3.31 Billion | 10.2 Billion | 2.53 Billion | 1.78 Billion |
| Other Investing Activities | -1.28 Million | -832.88 Thousand | -2.14 Million | -105.7 Thousand | 7.85 Million | -7.96 Million |
| Financing Cash Flow | -164.11 Million | -863.18 Million | 556.53 Million | -922.78 Million | 89.59 Million | 175.25 Million |
| Debt repayment | -151 Million | -406.79 Million | -1.34 Billion | -1.26 Billion | -476.56 Million | -196.56 Million |
| Dividends payments | -88.68 Million | -106 Million | -5.66 Million | -1.17 Billion | -1.17 Billion | -1.17 Billion |
| Common Stock Repurchased | - | -1.19 Billion | - | -999.99 Million | -999.99 Million | -3.75 Million |
| Common Stock Issuance | - | - | - | -975.56 Million | -975.56 Million | 3.75 Million |
| Other Financing Activities | -101.79 Million | -1.16 Billion | -791.67 Million | -9.2 Million | 1.79 Billion | 375.25 Million |
| Accounts receivables | - | -77.06 Million | - | 401.75 Million | 401.75 Million | -434.62 Million |
| Accounts payables | - | - | - | -279.88 Million | - | 144.1 Million |
| Inventory | - | 63.13 Million | - | 400.21 Million | 400.21 Million | -398.75 Million |
| Other working capital | - | 41.62 Million | - | 220.91 Million | 220.91 Million | -144.1 Million |
| Cash at beginning of period | 875.17 Million | 1.26 Billion | 2.24 Billion | 5.44 Billion | 1.46 Billion | 3.1 Billion |
| Cash at end of period | 2.88 Billion | 862.73 Million | 1.87 Billion | 2.24 Billion | 2.24 Billion | 1.45 Billion |
| Capital Expenditure | -6.97 Million | -27.47 Million | -815.44 Thousand | -212.65 Million | -14.78 Million | -6.28 Million |
| Effect of forex changes on cash | - | 7.27 Million | 4.64 Million | 69.44 Million | -7.27 Million | -45.35 Million |
| Net cash flow / Change in cash | 2.01 Billion | -398.63 Million | -376.8 Million | -3.19 Billion | 781.07 Million | -1.65 Billion |
| Free Cash Flow | 524.4 Million | 339.72 Million | 302.01 Million | 1.8 Billion | 6.72 Million | 106.77 Million |
FINKURVE
300219
600283
AMTL
CCLX
DEWM